This inventor holds 2 USPTO granted patents. Top assignees: University of Bern, University of Washington. Active years: 2006-2009.
Company Filing History:
2 out of 26 
2 out of 2,166 
Years Active: 2006-2009
Title: Kewei Gong: Innovator in Nucleic Acid Technologies
Introduction
Kewei Gong is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the field of nucleic acid technologies, holding 2 patents that focus on novel phosphodiesterase (PDE) proteins and their applications. His work has implications for the diagnosis, prevention, and treatment of various medical conditions.
Latest Patents
Gong's latest patents include innovative methods involving isolated full-length nucleic acid molecules that encode novel PDE proteins. These inventions also encompass peptide nucleic acids (PNA) and antisense molecules that interact with the nucleic acid molecules. The patents detail the development of agonists, antibodies, antagonists, or inhibitors that target the activity of these novel PDE proteins, providing valuable tools for addressing conditions related to their presence or deficiency.
Career Highlights
Throughout his career, Kewei Gong has worked at esteemed institutions such as the University of Washington and the University of Bern. His research has been pivotal in advancing our understanding of nucleic acid technologies and their potential applications in medicine.
Collaborations
Gong has collaborated with notable professionals in his field, including Joseph A. Beavo and Thomas Seebeck. These partnerships have further enriched his research and contributed to the development of innovative solutions in nucleic acid technologies.
Conclusion
Kewei Gong's contributions to the field of nucleic acid technologies highlight his role as an influential inventor. His patents and collaborations reflect a commitment to advancing medical science through innovative research.